Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Published:2016-08-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gallego-Durán Rocío,Cerro-Salido Pablo,Gomez-Gonzalez Emilio,Pareja María Jesús,Ampuero Javier,Rico María Carmen,Aznar Rafael,Vilar-Gomez Eduardo,Bugianesi Elisabetta,Crespo Javier,González-Sánchez Francisco José,Aparcero Reyes,Moreno Inmaculada,Soto Susana,Arias-Loste María Teresa,Abad Javier,Ranchal Isidora,Andrade Raúl Jesús,Calleja Jose Luis,Pastrana Miguel,Iacono Oreste Lo,Romero-Gómez Manuel

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31421.pdf

Reference49 articles.

1. Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases and American College of Gastroenterology. Gastroenterology 142, 1592–1609 (2012).

2. Wong, V. W. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012 61, 409–415 (2012).

3. Singh, S. et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13, 643–54 (2015).

4. Bellentani, S. & Marino, M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 8, S4–S8 (2009).

5. affy, G., Brunt, E. M. & Caldwell, S. H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J. Hepatol. 56, 1384–1391 (2012).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis;Metabolism and Target Organ Damage;2024-08-22

2. Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective;Heliyon;2024-03

3. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score;Liver International;2023-10-30

4. Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»;Gastroenterología y Hepatología;2023-03

5. AEEH "Consensus about detection and referral of hidden prevalent liver diseases";Gastroenterología y Hepatología (English Edition);2023-03